References
- Andersen TI, Heimdal KR, Skrede M, et al (1994). Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet, 94, 665-70.
- Antoniou AC, Easton DF (2006). Models of genetic susceptibility to breast cancer. Oncogene, 25, 5898-905. https://doi.org/10.1038/sj.onc.1209879
- Antoniou AC, Pharoah PD, McMullan G, et al (2002). A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer, 86, 76-83. https://doi.org/10.1038/sj.bjc.6600008
- Barzan D, Veldwijk MR, Herskind C, et al (2013). Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations. Eur J Hum Genet.
- Cai Q, Shu XO, Jin F, et al (2003). Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev, 12, 853-9.
- Chen W, Song H, Zhong R, et al (2013). Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis. Breast Cancer Res Treat, 142, 637-44. https://doi.org/10.1007/s10549-013-2775-8
- Chen W, Zhong R, Ming J, et al (2012). The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case-control study and a meta-analysis. Breast Cancer Res Treat, 136, 847-57. https://doi.org/10.1007/s10549-012-2309-9
- Chen WQ (2009). [Estimation of cancer incidence and mortality in China in 2004-2005]. Zhonghua Zhong Liu Za Zhi, 31, 664-8.
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Easton DF, Pooley KA, Dunning AM, et al (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-93. https://doi.org/10.1038/nature05887
- Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Gold B, Kalush F, Bergeron J, et al (2004). Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res, 64, 8891-900. https://doi.org/10.1158/0008-5472.CAN-04-1256
- Guo H, Ming J, Liu C, et al (2012). A common polymorphism near the ESR1 gene is associated with risk of breast cancer: evidence from a case-control study and a meta-analysis. PLoS One, 7, 52445. https://doi.org/10.1371/journal.pone.0052445
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Michailidou K, Hall P, Gonzalez-Neira A, et al (2013). Largescale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet, 45, 353-61. https://doi.org/10.1038/ng.2563
- Miki Y, Swensen J, Shattuck-Eidens D, et al (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71. https://doi.org/10.1126/science.7545954
- Mizoo T, Taira N, Nishiyama K, et al (2013). Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case--control study in Japanese women. BMC Cancer, 13, 565. https://doi.org/10.1186/1471-2407-13-565
- Nathanson KL, Wooster R, Weber BL (2001). Breast cancer genetics: what we know and what we need. Nat Med, 7, 552-6. https://doi.org/10.1038/87876
- Stacey SN, Manolescu A, Sulem P, et al (2007). Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet, 39, 865-9. https://doi.org/10.1038/ng2064
- Sueta A, Ito H, Kawase T, et al (2012). A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat, 132, 711-21. https://doi.org/10.1007/s10549-011-1904-5
- Turnbull C, Ahmed S, Morrison J, et al (2010). Genomewide association study identifies five new breast cancer susceptibility loci. Nat Genet, 42, 504-7. https://doi.org/10.1038/ng.586
- Wooster R, Bignell G, Lancaster J, et al (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-92. https://doi.org/10.1038/378789a0
- Xia P, Jin T, Geng T, et al (2013). Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population. Tumour Biol.
- Yang L, Li LD, Chen YD, Parkin DM (2006). Time trends, estimates and projects for breast cancer incidence and mortality in China. Zhonghua Zhong Liu Za Zhi, 28, 438-40 (in Chinese).
- Yoshimoto N, Nishiyama T, Toyama T, et al (2011). Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women. Cancer Sci, 102, 2065-72. https://doi.org/10.1111/j.1349-7006.2011.02047.x
- Zhang YX, Wang XM, Kang S, Li X, Geng J (2013). Common variants in the PALB2 gene confer susceptibility to breast cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 7149-54. https://doi.org/10.7314/APJCP.2013.14.12.7149
- Zhang ZH, Yang LS, Huang F, et al (2012). Current evidence on the relationship between two polymorphisms in the NBS1 gene and breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 5375-9. https://doi.org/10.7314/APJCP.2012.13.11.5375
- Zheng W, Long J, Gao YT, et al (2009). Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet, 41, 324-8. https://doi.org/10.1038/ng.318
Cited by
- Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population vol.24, pp.3, 2017, https://doi.org/10.1007/s12282-016-0712-5